文献速递生殖医学

自然周期冻融胚胎移植中应用hCG作为黄体期支持的随机双盲对照试验

A randomized double-blinded controlled trial of hCG as luteal phase support in natural cycle frozen embryo transfer.
PubMed 文献 · Hum Reprod · 2017-01-01

该随机双盲对照试验纳入450例自然周期冻融胚胎移植妇女,比较移植日及移植后6天给予1500 IU hCG与生理盐水对持续妊娠率的影响。结果hCG组持续妊娠率26.7%(60/225)与对照组31.3%(70/225)相当,比值比1.242(95%CI 0.825-1.869),着床率和流产率亦无差异。

要点

  • 自然周期冻融胚胎移植中,hCG组与对照组持续妊娠率无显著差异(26.7% vs 31.3%)。
  • 移植后6天,hCG组血清雌二醇水平显著更高,但血清孕酮水平相当。
  • 多因素logistic回归显示,移植胚胎数目是持续妊娠率的唯一显著预测因素。

核心结论

  • 自然周期冻融胚胎移植中使用hCG作为黄体期支持未提高持续妊娠率。
  • 研究结果不支持在自然周期冻融胚胎移植中使用hCG进行黄体期支持。

研究设计与样本

  • 随机双盲对照试验,2013年8月至2015年10月共招募450例月经规律行自然周期冻融胚胎移植的妇女。
  • 通过系列血清激素浓度确定自然排卵时间,移植至少第2天卵裂期胚胎。
  • 患者随机分为治疗组(移植日及移植后6天各给予1500 IU hCG)和对照组(相同时间给予生理盐水)。

主要发现

  • 持续妊娠率治疗组60/225(26.7%)vs 对照组70/225(31.3%),比值比1.242(95%CI 0.825-1.869)。
  • 两组的着床率和流产率相当。
  • 治疗组移植优质胚胎的周期数显著更多,移植后6天血清雌二醇水平显著更高,但血清孕酮水平相当。
  • 移植后6天,妊娠妇女与非妊娠妇女的血清雌二醇和孕酮水平无显著差异。
  • 多因素logistic回归中,移植胚胎数目是自然周期冻融胚胎移植后持续妊娠率的唯一显著预测因素。

关键数值与推荐

  • hCG用法:移植日及移植后6天各给予1500 IU hCG。
  • 对照组在相同两天给予生理盐水。

临床怎么用

  • 研究结果不支持在自然周期冻融胚胎移植中使用hCG作为黄体期支持。

局限性

  • 本研究仅纳入卵裂期胚胎的冻融胚胎移植。
  • 本研究仅使用hCG作为黄体期支持,未使用阴道孕酮。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does the use of hCG as luteal phase support in natural cycle frozen embryo transfer (FET) increase the ongoing pregnancy rate? STUDY ANSWER: The use of hCG in natural cycle FET did not improve the ongoing pregnancy rate. WHAT IS KNOWN ALREADY: The use of luteal phase support in stimulated cycles has been associated with higher live-birth rates and the results are similar when using hCG or progesterone. STUDY DESIGN SIZE, DURATION: This is a randomized double-blinded controlled trial of 450 women recruited between August 2013 and October 2015. PARTICIPANTS/MATERIALS SETTING METHODS: Women with regular cycles undergoing natural cycle FET were recruited. Serial serum hormonal concentrations were used to time natural ovulation and at least Day 2 cleavage embryos were replaced. Patients were randomized into either: (i) the treatment group, receiving 1500 IU hCG on the day of FET and 6 days after FET, or (ii) the control group, receiving normal saline on these 2 days. MAIN RESULTS AND THE ROLE OF CHANCE: The ongoing pregnancy rate [60/225 (26.7%) in the treatment group vs 70/225 (31.3%) in the control group, odds ratio 1.242 (95% CI 0.825-1.869)], implantation rate and miscarriage rate were comparable between the two groups. In the treatment group, there were significantly more cycles with top quality embryos transferred and a significantly higher serum oestradiol level, but a comparable serum progesterone level, 6 days after FET. However, no significant differences were observed in serum oestradiol and progesterone levels 6 days after FET between the pregnant and non-pregnant women. In the multivariate logistic regression, the number of embryos transferred was the only significant factor predictive of the ongoing pregnancy rate after natural cycle FET. LIMITATIONS REASON FOR CAUTION: This study only included FET with cleavage stage embryos and only hCG, not vaginal progesterone, was used as luteal phase support. WIDER IMPLANTATIONS OF THE FINDINGS: The findings in this study do not support the use of hCG for luteal phase support in natural cycle FET. STUDY FUNDING/COMPETING INTERESTS: No external funding was used and there were no competing interests. TRIAL REGISTRATION NUMBER: clinicaltrial.gov identifier: NCT01931384. TRIAL REGISTRATION DATE: 23/8/2013. DATE OF FIRST PATIENT'S ENROLMENT: 30/8/2013.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Lee VCY, Li RHW, Yeung WSB, et al. A randomized double-blinded controlled trial of hCG as luteal phase support in natural cycle frozen embryo transfer. Hum Reprod. 2017. PMID: 28333292. doi:10.1093/humrep/dex049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。